Table 4.
Detectable Change in MHI (>21%) | Age, y | n | % n | Male | Female | Variable | Baseline Mean (95% CI) | 8-wk Follow-up Mean (95% CI) | P |
---|---|---|---|---|---|---|---|---|---|
All treated | 39 ± 13 | 21 | 70 (21/30) | 9 | 12 | MHI | 0.18 (0.16–0.20) | 0.14 (0.11–0.17) | .030 |
PPT | 6.50 (5.39–7.61) | 9.10 (7.99–10.21) | .0014 | ||||||
Responded | 39 ± 13 | 14 | 64 (14/22) | 7 | 7 | MHI | 0.18 (0.16–0.20) | 0.09 (0.08–0.11) | <.0001 |
PPT | 6.90 (5.59–8.21) | 9.40 (8.04–10.76) | .022 | ||||||
Resolved | 43 ± 12 | 8 | 80 (8/10) | 4 | 4 | MHI | 0.16 (0.14–0.19) | 0.08 (0.06–0.10) | .0002 |
PPT | 7.60 (5.52–9.68) | 10.30 (8.57–12.03) | 0.10 |
Notations are as in Table 1.